Pediatrix Medical Group, Inc. $MD is SummerHaven Investment Management LLC’s 4th Largest Position

SummerHaven Investment Management LLC increased its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 1.0% in the second quarter, HoldingsChannel reports. The firm owned 113,480 shares of the company’s stock after purchasing an additional 1,153 shares during the quarter. Pediatrix Medical Group accounts for approximately 1.1% of SummerHaven Investment Management LLC’s holdings, making the stock its 4th biggest holding. SummerHaven Investment Management LLC’s holdings in Pediatrix Medical Group were worth $1,628,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Nuveen LLC bought a new position in Pediatrix Medical Group during the 1st quarter valued at approximately $8,024,000. Teacher Retirement System of Texas increased its position in Pediatrix Medical Group by 92.3% during the 1st quarter. Teacher Retirement System of Texas now owns 371,756 shares of the company’s stock valued at $5,387,000 after buying an additional 178,386 shares in the last quarter. Hussman Strategic Advisors Inc. bought a new position in Pediatrix Medical Group during the 1st quarter valued at approximately $1,217,000. Invesco Ltd. increased its position in Pediatrix Medical Group by 9.3% during the 1st quarter. Invesco Ltd. now owns 863,269 shares of the company’s stock valued at $12,509,000 after buying an additional 73,157 shares in the last quarter. Finally, Public Sector Pension Investment Board increased its position in Pediatrix Medical Group by 27.3% during the 1st quarter. Public Sector Pension Investment Board now owns 268,076 shares of the company’s stock valued at $3,884,000 after buying an additional 57,463 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Up 0.0%

Pediatrix Medical Group stock opened at $16.35 on Monday. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of 12.67 and a beta of 1.29. The stock has a fifty day simple moving average of $15.40 and a two-hundred day simple moving average of $14.31. Pediatrix Medical Group, Inc. has a 12 month low of $11.04 and a 12 month high of $17.67. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.11. The business had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The company’s quarterly revenue was down 7.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.34 EPS. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Wall Street Zen lowered Pediatrix Medical Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 13th. Leerink Partners raised their price objective on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Zacks Research raised Pediatrix Medical Group to a “strong-buy” rating in a research report on Monday, August 11th. Finally, UBS Group raised their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.79.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.